4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Panic Disorder: new trials by email Literature Review of Panic Disorder trials Research Report on Panic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder placebo, alprazolam XR - Panic Disorder | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 | 2004-07-01 | 2021-01-28 |
| A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks alprazolam XR - Panic Disorder | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 49 | 2004-05-01 | 2021-01-28 |
| A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder placebo, alprazolam XR - Panic Disorder | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 16 | 2004-04-01 | 2021-01-28 |
| Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Sertraline, Placebo - Phobia, Social, Panic Disorder | Phase 4 | Terminated | Hamilton Health Sciences Corporation | 170 | 2002-07-01 | 2018-03-22 |
Agoraphobia (1) · Anxiety Disorders (1) · Depressive Disorder, Major (1) · Dysthymic Disorder (1) · Obsessive-Compulsive Disorder (1) · Phobia, Social (1)
Mental Disorders (4) · Anxiety Disorders (3) · Depressive Disorder (1) · Mood Disorders (1) · Phobic Disorders (1)
Alprazolam (3) · Sertraline (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (3) · Hamilton Health Sciences Corporation (1)
United States (3) · Canada (1)